Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (241-250 of 280) with videos related to

Pageof 28
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2017
The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis CZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2021
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic ResponseZobair M Younossi, Andrei Racila, Andrew Muir, et al.
Hepatology Communications|April 30, 2025
Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver diseaseAlina M Allen, Jeffrey V Lazarus, Naim Alkhouri, et al.
Digestive Diseases (Basel, Switzerland)|February 3, 2021
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South KoreaJiyoon Park, Eunice Yewon Lee, Jie Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2018
Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral PracticesVy H Nguyen, An K Le, Huy N Trinh, et al.
Hepatology Communications|September 24, 2021
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 InfectionZobair M Younossi, Maria Stepanova, Brian Lam, et al.
BMC Infectious Diseases|August 22, 2022
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19Maria Stepanova, Brian Lam, Elena Younossi, et al.
The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2021
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World ExperienceJohn Paul Verderese, Maria Stepanova, Brian Lam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority AgendaMohamed El-Kassas, Marcela Villota-Rivas, Khalid A Alswat, et al.
Pageof 28

Showing results (241-250 of 280) with videos related to

Sort By:
Pageof 28
Liver International : Official Journal of the International Association for the Study of the Liver|December 3, 2017
The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis CZobair M Younossi, Maria Stepanova, Linda Henry, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 25, 2021
Long-term Patient-Centered Outcomes in Cirrhotic Patients With Chronic Hepatitis C After Achieving Sustained Virologic ResponseZobair M Younossi, Andrei Racila, Andrew Muir, et al.
Hepatology Communications|April 30, 2025
Global patterns of utilization of noninvasive tests for the clinical management of metabolic dysfunction-associated steatotic liver diseaseAlina M Allen, Jeffrey V Lazarus, Naim Alkhouri, et al.
Digestive Diseases (Basel, Switzerland)|February 3, 2021
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South KoreaJiyoon Park, Eunice Yewon Lee, Jie Li, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 17, 2018
Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral PracticesVy H Nguyen, An K Le, Huy N Trinh, et al.
Hepatology Communications|September 24, 2021
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 InfectionZobair M Younossi, Maria Stepanova, Brian Lam, et al.
BMC Infectious Diseases|August 22, 2022
The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19Maria Stepanova, Brian Lam, Elena Younossi, et al.
The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2021
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World ExperienceJohn Paul Verderese, Maria Stepanova, Brian Lam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease in the MENA Region: Setting a Research and Action Priority AgendaMohamed El-Kassas, Marcela Villota-Rivas, Khalid A Alswat, et al.
Pageof 28